human | Q5 |
P3835 | Mendeley person ID | michael-schmidt38 |
P496 | ORCID iD | 0000-0001-8141-2944 |
P734 | family name | Schmidt | Q15240355 |
P735 | given name | J. | Q19803507 |
J. | Q19803507 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q48168403 | Acute cerebral microbleeds in refractory status epilepticus |
Q48837195 | Acute effects of intraventricular nicardipine on cerebral hemodynamics: A preliminary finding |
Q48702013 | Acute effects of nimodipine on cerebral vasculature and brain metabolism in high grade subarachnoid hemorrhage patients |
Q43103440 | Anemia is associated with metabolic distress and brain tissue hypoxia after subarachnoid hemorrhage. |
Q40785141 | Assessment of Noninvasive Regional Brain Oximetry in Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome |
Q48665847 | Brain injury visible on early MRI after subarachnoid hemorrhage might predict neurological impairment and functional outcome |
Q83499143 | Can quantitative EEG reliably predict deterioration from delayed cerebral ischemia secondary to vasospasm? |
Q34018874 | Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome |
Q46273306 | Cardiac output augmentation with fluid resuscitation improves brain tissue oxygenation after severe brain injury |
Q36001623 | Causal Structure of Brain Physiology after Brain Injury from Subarachnoid Hemorrhage |
Q80686406 | Cerebral infarction associated with acute subarachnoid hemorrhage |
Q33697166 | Cerebral inflammatory response and predictors of admission clinical grade after aneurysmal subarachnoid hemorrhage |
Q43487107 | Cerebral microbleeds in patients with acute subarachnoid hemorrhage |
Q34951946 | Cerebral perfusion pressure thresholds for brain tissue hypoxia and metabolic crisis after poor-grade subarachnoid hemorrhage |
Q48239041 | Cerebrovascular carbon dioxide reactivity and delayed cerebral ischemia after subarachnoid hemorrhage |
Q82373157 | Cerebrovascular reactivity and vasospasm after subarachnoid hemorrhage: a pilot study |
Q82297039 | Clinical response to hypertensive hypervolemic therapy and outcome after subarachnoid hemorrhage |
Q82691642 | Clinical utility of brain tissue oxygen tension in treatment of brain injury more complicated than it appears |
Q30924720 | Data collection and interpretation. |
Q39880670 | Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? |
Q36637976 | Early neurological deterioration after subarachnoid haemorrhage: risk factors and impact on outcome |
Q37795389 | Effect of mannitol on brain metabolism and tissue oxygenation in severe haemorrhagic stroke |
Q46275163 | Effect of packed red blood cell transfusion on cerebral oxygenation and metabolism after subarachnoid hemorrhage |
Q36304075 | Effect of rebleeding on the course and incidence of vasospasm after subarachnoid hemorrhage |
Q38051271 | Effectiveness and safety of nicardipine and labetalol infusion for blood pressure management in patients with intracerebral and subarachnoid hemorrhage. |
Q36902791 | Effects of the neurological wake-up test on clinical examination, intracranial pressure, brain metabolism and brain tissue oxygenation in severely brain-injured patients |
Q55346115 | Electrographic seizures after subarachnoid hemorrhage lead to derangement of brain homeostasis in humans. |
Q46286323 | Ethnic disparities in end-of-life care after subarachnoid hemorrhage |
Q48134598 | External ventricular drainage response in poor grade aneurysmal subarachnoid hemorrhage: effect on preoperative grading and prognosis |
Q48966999 | Fluid responsiveness and brain tissue oxygen augmentation after subarachnoid hemorrhage |
Q34344828 | Free Fatty acids and delayed cerebral ischemia after subarachnoid hemorrhage |
Q82736409 | Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage |
Q51475637 | Global cerebral edema and brain metabolism after subarachnoid hemorrhage |
Q82769038 | High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: prolonged effects on hemodynamic parameters and brain metabolism |
Q37593258 | High-dose midazolam infusion for refractory status epilepticus |
Q48769090 | Hyperoxia may be related to delayed cerebral ischemia and poor outcome after subarachnoid haemorrhage |
Q40484529 | Impact of medical complications on outcome after subarachnoid hemorrhage |
Q51713381 | Impact of nosocomial infectious complications after subarachnoid hemorrhage |
Q46018920 | Impact of premorbid hypertension on haemorrhage severity and aneurysm rebleeding risk after subarachnoid haemorrhage. |
Q46308100 | Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study |
Q35106607 | Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage |
Q45363415 | Intracerebral monitoring of silent infarcts after subarachnoid hemorrhage |
Q48116063 | Intracortical EEG for the detection of vasospasm in patients with poor-grade subarachnoid hemorrhage |
Q43520407 | Intracortical electroencephalography in acute brain injury |
Q37682677 | Intracranial multimodal monitoring for acute brain injury: a single institution review of current practices |
Q35154916 | Intraventricular hemorrhage expansion in patients with spontaneous intracerebral hemorrhage |
Q33892365 | Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study. |
Q37800041 | Left ventricular dysfunction and cerebral infarction from vasospasm after subarachnoid hemorrhage |
Q53221207 | Long-term domain-specific improvement following poor grade aneurysmal subarachnoid hemorrhage |
Q40329103 | Loss of Consciousness at Onset of Subarachnoid Hemorrhage as an Important Marker of Early Brain Injury. |
Q92522004 | Medical Treatment Failure for Symptomatic Vasospasm After Subarachnoid Hemorrhage Threatens Long-Term Outcome |
Q48650654 | Metabolic benefits of surface counter warming during therapeutic temperature modulation |
Q40407087 | Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale |
Q81560046 | Monocyte chemoattractant protein-1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhage |
Q35449746 | Multimodality monitoring for cerebral perfusion pressure optimization in comatose patients with intracerebral hemorrhage |
Q36953769 | Multimodality monitoring in neurocritical care |
Q35246499 | Multimodality monitoring: informatics, integration data display and analysis |
Q30544942 | Nonconvulsive seizures after subarachnoid hemorrhage: Multimodal detection and outcomes |
Q33856333 | Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome |
Q36093519 | Nutritional support and brain tissue glucose metabolism in poor-grade SAH: a retrospective observational study. |
Q36376183 | Patient-Powered Reporting of Modified Rankin Scale Outcomes Via the Internet. |
Q35758678 | Pearls & Oysters: the effects of renal replacement therapy on cerebral autoregulation |
Q82600888 | Predicting long-term outcome in poor grade aneurysmal subarachnoid haemorrhage patients utilising the Glasgow Coma Scale |
Q53530587 | Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale |
Q40373407 | Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage |
Q39885928 | Predictors of long-term shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage. Clinical article. |
Q42597555 | Preoperative prediction of long-term outcome in poor-grade aneurysmal subarachnoid hemorrhage |
Q40338227 | Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol. |
Q93258204 | Prognostic Significance of Sentinel Headache Preceding Aneurysmal Subarachnoid Hemorrhage |
Q35623045 | Prolonged elevated heart rate is a risk factor for adverse cardiac events and poor outcome after subarachnoid hemorrhage |
Q50995112 | Quantitative analysis of hemorrhage clearance and delayed cerebral ischemia after subarachnoid hemorrhage |
Q48524255 | Quantitative analysis of hemorrhage volume for predicting delayed cerebral ischemia after subarachnoid hemorrhage |
Q36297701 | Real time estimation of brain water content in comatose patients |
Q48964653 | Reduced brain/serum glucose ratios predict cerebral metabolic distress and mortality after severe brain injury |
Q49047694 | Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage |
Q46001653 | Renal dysfunction as an independent predictor of outcome after aneurysmal subarachnoid hemorrhage: a single-center cohort study. |
Q37400544 | Resuscitation and critical care of poor-grade subarachnoid hemorrhage |
Q40243528 | Risk factors for catheter-associated urinary tract infections in critically ill patients with subarachnoid hemorrhage |
Q30703796 | Seizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome |
Q45747805 | Serum glucose variability and brain-serum glucose ratio predict metabolic distress and mortality after severe brain injury |
Q48386518 | Spontaneous hyperventilation and brain tissue hypoxia in patients with severe brain injury |
Q48851697 | Status epilepticus-induced hyperemia and brain tissue hypoxia after cardiac arrest |
Q36015756 | Subarachnoid hemorrhage: who dies, and why? |
Q33752318 | Systemic glucose variability predicts cerebral metabolic distress and mortality after subarachnoid hemorrhage: a retrospective observational study |
Q34949499 | Tonic-clonic activity at subarachnoid hemorrhage onset: impact on complications and outcome |
Q48510644 | Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. |
Q48647125 | Transcranial Doppler ultrasound in the acute phase of aneurysmal subarachnoid hemorrhage |
Q85200231 | Transdermal nicotine replacement therapy in cigarette smokers with acute subarachnoid hemorrhage |
Q39731872 | Ultra-early angiographic vasospasm associated with delayed cerebral ischemia and infarction following aneurysmal subarachnoid hemorrhage. |